The HDAC Inhibitor Vorinostat Diminishes the In Vitro Metastatic Behavior of Osteosarcoma Cells

Figure 3

Invasion assays of untreated and vorinostat-treated (50 μM) K7M2 cells through a semisolid matrigel matrix. There was a significant inhibition of invasion in vorinostat-treated cells.